Fragment-based drug discovery

This paid-for advertorial by SCIEX appeared in DDW Volume 24 – Issue 2, Spring 2023 Imagine having the ability to consistently identify metabolic soft spots from an experiment that uses liquid chromatography coupled to mass spectrometry (LC-MS), reducing the need for additional safety testing in the drug discovery phase. Metabolite identification A key step in the drug […]

Astex Pharmaceuticals and The Medicines Discovery Institute, Cardiff University (MDI) have agreed a multi-year, multimillion pound drug discovery research collaboration, aimed to identify new drugs to treat neurodegenerative diseases.    The collaboration brings together the research expertise of Dr Emyr Lloyd-Evans and Dr Helen Waller-Evans in lysosomal biology, the drug discovery capabilities of the MDI and […]

Don’t miss your chance to register for the free webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. The event will take place on Thursday, October 13 at 3PM BST, 4PM CET, 10AM EST, 7AM PDT. Attendees will learn: How FBDD can help identify novel and potent lead compounds.   The benefits […]

Fragment-based drug discovery (FBDD) is one strategy used to identify novel and potent lead compounds.   Don’t miss out on this free webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. Fragments are small molecules with a low molecular weight (less than 250 g/mol). The FBDD technology is based on identifying these small […]

Fragment-based drug discovery (FBDD) is one strategy of hit identification (hit ID) in the drug discovery process. Watch the webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. Key Learning Objectives:   How FBDD can help identify novel and potent lead compounds.   Understand the benefits of FBDD technology compared to high throughput screening […]

Watch the free webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification (hit ID) in the drug discovery process. Fragments are small molecules with a low molecular weight (less than 250 g/mol). […]

Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification (hit ID) in the drug discovery process.   Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec, is now available to watch online.  Fragments are small molecules with a low molecular weight (less […]

Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification (hit ID) in the drug discovery process.   Watch this free event, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec.  Fragments are small molecules with a low molecular weight (less than 250 g/mol). […]